Treatment for secondary adrenal insufficiency centers on replacing the cortisol your body can no longer produce in adequate amounts, typically with oral hydrocortisone taken in divided daily doses that mimic the body’s natural rhythm. Guidelines generally recommend somewhere between 15 and 25 mg of hydrocortisone per day for an otherwise healthy adult, though there is growing evidence that many people do well on less.1PubMed Central. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review Getting the dose right is surprisingly tricky, and the management extends well beyond a simple pill: it involves stress dosing during illness, navigating interactions with other hormones, and long-term monitoring to avoid the consequences of too much or too little cortisol.
Why Secondary Adrenal Insufficiency Happens
Secondary adrenal insufficiency develops when the pituitary gland fails to produce enough adrenocorticotropic hormone (ACTH), the signal that tells the adrenal glands to make cortisol. The most common cause, by a wide margin, is long-term use of glucocorticoid medications like prednisone, inhaled steroids, or even potent topical creams. When you take external glucocorticoids for a month or more, the brain’s feedback loop shuts down its own ACTH production because it detects plenty of cortisol-like activity already circulating. Once those medications are stopped or reduced, the pituitary may not bounce back immediately, leaving the adrenals without their instructions.2PubMed Central. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency Other causes include pituitary tumors, pituitary surgery or radiation, head trauma, and, increasingly, a side effect of cancer immunotherapy drugs.
One important clinical distinction: unlike primary adrenal insufficiency (Addison’s disease), the secondary form usually spares your aldosterone production. Aldosterone is made through a different signaling pathway that does not depend on ACTH, so most people with secondary adrenal insufficiency do not need a mineralocorticoid replacement and do not develop the salt cravings or dangerous potassium swings seen in primary disease.3The Lancet. Adrenal insufficiency That simplifies treatment somewhat, but cortisol replacement itself carries enough complexity to keep endocrinologists busy.
Standard Glucocorticoid Replacement
Hydrocortisone is the most commonly prescribed glucocorticoid for secondary adrenal insufficiency because it is chemically identical to the cortisol your body makes. The standard recommendation is 15 to 25 mg daily, split into two or three doses, with the largest dose taken first thing in the morning to replicate the natural cortisol peak that occurs around waking.4PubMed Central. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review A typical regimen might look like 10 mg on waking, 5 mg at midday, and 5 mg in the late afternoon, though your endocrinologist will adjust to your weight, symptoms, and how your body handles the drug.
Some clinicians prescribe prednisolone instead, at roughly 3 to 5 mg per day, because it has a longer duration of action and lets people take fewer doses. The trade-off is less flexibility for fine-tuning, and prednisolone does not mirror the body’s natural cortisol profile as closely as hydrocortisone does. A randomized trial that compared a lower hydrocortisone dose (roughly 0.2 to 0.3 mg per kilogram of body weight per day) against a higher dose (0.4 to 0.6 mg per kilogram) found that the dose range meaningfully affects how people function day to day, reinforcing that one size does not fit all.5PubMed. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency–results from a randomized controlled trial
There is a real tension in dosing. The guideline midpoint of 20 mg per day may actually overshoot what many people need. When researchers calculate how much cortisol a healthy body produces each day and factor in how well oral hydrocortisone is absorbed, the predicted replacement dose comes out closer to 15 mg for some people. Higher guideline doses risk chronic over-replacement, which carries its own set of problems.6PubMed Central. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review The practical upshot is that your dose should be individualized through careful monitoring of symptoms, body weight, and bone health rather than locked into a textbook number.
The Problem with Over-Replacement
Cortisol replacement that creeps even a little above what the body needs, sustained over years, behaves like a slow-acting toxin on bones and metabolism. A six-year study tracking bone density in patients on glucocorticoid replacement found that higher body-surface-area-adjusted doses predicted significantly worse bone density at the hip and femoral neck.7Journal of the Endocrine Society. Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study That is particularly concerning because the effect accumulates quietly: you do not feel bone thinning until a fracture happens. Over-replacement also contributes to weight gain, elevated blood sugar, and cardiovascular risk factors that compound over time.
Despite optimized replacement therapy, quality of life in adrenal insufficiency remains more impaired than many clinicians once assumed.8The Lancet. Adrenal insufficiency Fatigue, brain fog, and a general sense of diminished well-being are common complaints, and they can persist even when lab values look acceptable. This lingering impairment is one reason researchers have pushed hard to develop better delivery systems for hydrocortisone.
Extended-Release and Dual-Release Formulations
Standard hydrocortisone tablets release their payload quickly, creating a spike-and-trough pattern that does not perfectly match the smooth rise and fall of natural cortisol. Extended-release and dual-release formulations attempt to fix that. Plenadren, a once-daily modified-release hydrocortisone tablet, has been studied most extensively. When patients switch from immediate-release hydrocortisone to the modified-release version at the same nominal dose, total daily cortisol exposure drops by about 20 percent because of the way the drug is absorbed. That reduction alone may explain most of the metabolic improvements seen in studies, including reductions in weight, body mass index, fat mass, and better blood sugar control.9The Journal of Clinical Endocrinology & Metabolism. Extended-release Hydrocortisone Formulations—Is There a Clinically Meaningful Benefit?
Research specifically in secondary adrenal insufficiency confirms these benefits. One study found that switching to dual-release hydrocortisone significantly reduced waist circumference and body mass index over six months and improved quality-of-life scores, particularly in the emotional domain.10PubMed Central. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency Another showed reductions in total body fat (about 1.5 kg) and abdominal fat (about 0.5 kg) after the switch, along with lower late-evening cortisol levels, a decrease in HbA1c (a marker of blood sugar control), and reduced evening cortisol exposure.11PubMed Central. Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency
Whether these improvements come from the smoother pharmacokinetic profile or simply from the lower total cortisol exposure remains an open question. The answer matters because if the benefit is purely dose-related, you might achieve the same results by lowering the dose of standard hydrocortisone rather than switching to an expensive modified-release product.12The Journal of Clinical Endocrinology & Metabolism. Extended-release Hydrocortisone Formulations—Is There a Clinically Meaningful Benefit? Modified-release formulations are not universally available and can be significantly more expensive, so cost and access factor into the decision for many patients.
Stress Dosing and Adrenal Crisis Prevention
When you are healthy, your adrenal glands ramp up cortisol output during physical stress like fevers, injuries, or surgery. If you have secondary adrenal insufficiency, that surge cannot happen, and your usual replacement dose may be dangerously inadequate during illness. An adrenal crisis, the acute failure of cortisol supply during stress, is a medical emergency with symptoms that include severe low blood pressure, shock, abdominal pain, and confusion. It can be fatal.
The rules for stress dosing are straightforward in principle but often poorly followed in practice. For a minor illness with fever, most guidelines call for doubling or tripling the daily hydrocortisone dose. For major illness or surgery, intravenous hydrocortisone at higher doses is needed. Every patient should be educated on how to adjust their own dose during illness, trained in self-injection of emergency hydrocortisone, and equipped with a medical alert bracelet or card identifying them as steroid-dependent.13PubMed Central. Adrenal crisis: prevention and management in adult patients Unfortunately, studies consistently show that many patients have never been taught these skills, and a large proportion have experienced at least one crisis.
Perioperative care deserves special attention. Joint guidelines from several UK professional bodies emphasize that patients on physiological replacement doses for adrenal insufficiency are at significant risk of crisis during surgery and must receive stress-dose hydrocortisone in the perioperative period. The same guidelines note that anyone who has taken the equivalent of 5 mg or more of prednisolone daily for a month or longer by any route, including inhaled or topical steroids, may have a suppressed axis and should be considered at risk.14PubMed Central. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency
Tapering Off Glucocorticoids and HPA Axis Recovery
When secondary adrenal insufficiency is caused by exogenous steroid use, there is at least a chance the pituitary-adrenal axis will recover if steroids are tapered carefully. The general approach involves reducing doses relatively quickly down to a physiological replacement level, then slowing the taper dramatically once you are near that baseline, spacing reductions over weeks or months to give the axis time to reawaken. A useful rule of thumb: the longer the axis was suppressed, the slower the taper needs to be, sometimes stretching over a year.15PubMed Central. The Glucocorticoid Taper: A Primer for the Clinicians
Recovery is not guaranteed. In a case series of patients with severe asthma who underwent structured glucocorticoid tapering, half were able to fully discontinue hydrocortisone and showed basal cortisol levels above the threshold indicating recovery. The other half remained on low replacement doses because their cortisol stayed suppressed.16PubMed Central. Structured tapering of oral corticosteroids in patients with severe asthma at risk of secondary adrenal insufficiency: a case series During any taper, you need periodic morning cortisol checks or stimulation tests to track whether the axis is recovering before further dose cuts are made.
When the Cause Is Cancer Immunotherapy
Immune checkpoint inhibitors, a class of cancer drugs that includes agents targeting PD-1 and CTLA-4, can inflame the pituitary gland in a condition called hypophysitis. This is becoming an increasingly common cause of secondary adrenal insufficiency as immunotherapy use grows. The resulting ACTH deficiency often appears alongside deficiencies in other pituitary hormones, including thyroid-stimulating hormone in about half of cases.17PubMed. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival
Diagnosing immunotherapy-induced hypophysitis is tricky because the classic pituitary enlargement often seen with CTLA-4 inhibitors may be absent when PD-1 or PD-L1 inhibitors are the culprits. Clinicians also have to distinguish whether a patient’s adrenal insufficiency is genuinely from pituitary damage or simply from the high-dose steroids commonly given to manage other immune side effects. That distinction matters for prognosis and long-term management.
Recovery from immunotherapy-induced secondary adrenal insufficiency is extremely rare. While the thyroid and gonadal axes sometimes bounce back, the ACTH-producing cells appear particularly vulnerable to permanent damage. Only a handful of recovery cases have been reported in the medical literature, and no consistent patient factors or treatment strategies have been identified that predict who might recover.18Journal for ImmunoTherapy of Cancer. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis For most patients, this means lifelong hydrocortisone replacement.
Interactions with Growth Hormone and Thyroid Treatment
Many people with secondary adrenal insufficiency also have other pituitary hormone deficiencies, and treating those can destabilize cortisol balance in unexpected ways. Growth hormone replacement is a well-known culprit. Growth hormone (and its downstream mediator, IGF-1) shifts how the body converts between active cortisol and its inactive form, cortisone. Specifically, growth hormone inhibits the enzyme that converts cortisone back into cortisol. In someone with borderline ACTH reserve, starting growth hormone therapy can tip them into overt adrenal insufficiency by accelerating cortisol clearance.19PubMed. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle For this reason, cortisol status should always be reassessed when growth hormone treatment begins.
Thyroid hormone replacement carries a similar risk. Levothyroxine speeds up overall metabolism, including the clearance of cortisol. Starting thyroid replacement without first ensuring adequate cortisol supply can precipitate an adrenal crisis. A published case dramatically illustrates this: a patient given levothyroxine for hypothyroidism without recognition of underlying adrenal insufficiency developed severe hypotension, low blood sugar, and cardiac arrest requiring mechanical circulatory support.20PubMed Central. Initiation of levothyroxine in a patient with hypothyroidism inducing adrenal crisis requiring VA ECMO: a tale of preventable disaster The lesson, critical for anyone with panhypopituitarism, is that cortisol replacement must always be established before or at the same time as thyroid replacement. Getting this sequence wrong can be life-threatening.
DHEA Supplementation
The adrenal glands produce more than just cortisol. They also make DHEA, a precursor to sex hormones. In secondary adrenal insufficiency, DHEA production often falls along with cortisol, and standard hydrocortisone replacement does nothing to correct that deficit. Low DHEA levels have been linked to reduced libido, fatigue, and diminished sense of well-being, particularly in women.
DHEA supplementation has been explored mainly in women with hypopituitarism and documented low DHEA levels. Short-term studies suggest it may improve energy, mood, and sexual function in some women, though androgenic side effects like acne and unwanted hair growth limit its acceptability for others. Long-term safety data are lacking, and the evidence is not strong enough for routine recommendation.21PubMed. Androgen replacement therapy in androgen-deficient women with hypopituitarism Some endocrinologists offer a trial of 25 to 50 mg daily to women who remain symptomatic despite optimized cortisol replacement, treating it as an individualized decision rather than a standard part of the regimen.
Pregnancy and Dose Adjustments
Pregnancy increases cortisol demand substantially, and women with secondary adrenal insufficiency typically need dose adjustments as the pregnancy progresses. In a multicenter survey, more than half of pregnant women with adrenal insufficiency had their glucocorticoid dose increased at some point, with an average increase of about 8 to 9 mg of hydrocortisone equivalent between baseline and the third trimester.22PubMed Central. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey Stress dosing is also required during labor and delivery. Close coordination between the endocrinologist and obstetrician throughout pregnancy is standard practice.
Dosing in Children
Children with secondary adrenal insufficiency require careful dose calibration because the stakes of getting it wrong run in both directions. Under-replacement risks dangerous hypoglycemia and adrenal crisis. Over-replacement suppresses growth and can permanently reduce adult height.23PubMed. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism Growth velocity is one of the most sensitive clinical markers of excess glucocorticoid in children, often flagging a dosing problem before any lab test does. Pediatric dosing is typically calculated by body surface area rather than fixed milligrams, and reassessed frequently as the child grows.
Shift Work, Timing Challenges, and Nocturnal Hypoglycemia
The conventional dosing schedule, with the largest dose in the morning, assumes you live on a typical day-night cycle. Shift workers face a genuine problem. A survey of patients with adrenal insufficiency found that about 20 percent regularly struggled to take their glucocorticoid on time, another 40 percent had occasional difficulties, and nearly half had forgotten doses at some point. More than half reported an adrenal crisis in the prior two years. How patients adapted their dosing schedules to night shifts varied widely, and no evidence-based protocol currently exists for this population.24PubMed Central. Time Adjustment of Hydrocortisone Doses During Shift Work in Patients with Adrenal Insufficiency
Even for people on standard schedules, nighttime cortisol levels drop to near zero on conventional hydrocortisone, which can cause unrecognized hypoglycemia during sleep. In a small study using continuous glucose monitoring, five out of six patients with central adrenal insufficiency had undetected low blood sugar episodes in the midnight-to-early-morning window. Adjusting hydrocortisone timing and dosing based on the glucose data eliminated the nocturnal drops and improved daytime symptoms as well.25PubMed Central. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism This is not standard practice yet, but it highlights how much hidden trouble conventional dosing can cause and why symptoms like morning headaches, nightmares, or unexplained fatigue deserve investigation.
Monitoring That Goes Beyond Blood Tests
Unlike thyroid or diabetes management, there is no single lab value that reliably tells you whether your hydrocortisone dose is right. Random cortisol levels fluctuate too much to be useful. Cortisol day curves, where blood is drawn several times throughout the day after a dose, give more information but are cumbersome and not widely standardized. Urinary free cortisol can signal chronic overexposure but misses short-lived peaks and troughs.
In practice, monitoring relies heavily on clinical judgment: how you feel, whether your weight is stable, what your blood pressure and blood sugar are doing, and whether your bones are holding up on periodic density scans. The subjective element is both a strength and a frustration. It is a strength because it forces attention to the patient as a whole rather than a lab number. It is a frustration because fatigue and malaise, the most common symptoms of both under-replacement and over-replacement, overlap extensively, making it hard to know which direction the dose should move. Disease-specific quality-of-life questionnaires are sometimes used in research settings, but they have not become routine clinical tools.
Living with an Emergency Injection Kit
Every person with secondary adrenal insufficiency should have an emergency hydrocortisone injection kit at home, at work, and while traveling. Intramuscular injection of 100 mg hydrocortisone is the standard emergency dose for adults who are vomiting and cannot keep oral medication down, or who show signs of impending crisis. Partners, family members, or close colleagues should know where the kit is and how to administer it. Some patients carry prefilled syringes; others use a reconstitution kit with a vial and needle. Training needs to be hands-on and refreshed periodically, because the skill degrades quickly if never practiced. In real emergencies, the barrier to using the injection is often psychological rather than technical: people hesitate to inject themselves or a loved one, and that delay costs precious time.26PubMed Central. Adrenal crisis: prevention and management in adult patients